← back to search

Kai Schönig

Central Institute of Mental Health ·
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Cancer-related Molecular Pathways, Neuroscience and Neuropharmacology Research, Molecular Biology Techniques and Applications, and Virus-based gene therapy research.
h-index
29
citations
4,808
works
129
NIH funding
primary concept
email

Recent publications

A Clathrin light chain A reporter mouse for in vivo imaging of endocytosis
PLoS ONE 2022cited by 4position: middledoi
CRISPR-Cas9 mediated generation of a conditional poly(A) binding protein nuclear 1 (Pabpn1) mouse model reveals an essential role for hematopoietic stem cells
Scientific Reports 2022cited by 3position: middledoi
RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas
Acta Neuropathologica 2019cited by 9position: middledoi
Inducible knockdown of procollagen I protects mice from liver fibrosis and leads to dysregulated matrix genes and attenuated inflammation
Matrix Biology 2017cited by 29position: middledoi
Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR
Genome biology 2016cited by 1,856position: middledoi
Reduced Expression of Nogo-A Leads to Motivational Deficits in Rats
Frontiers in Behavioral Neuroscience 2014cited by 17position: middledoi
Postnatal subventricular zone progenitors switch their fate to generate neurons with distinct synaptic input patterns
Development 2014cited by 2position: middledoi
Corrigendum: Nogo-A-deficient transgenic rats show deficits in higher cognitive functions, decreased anxiety, and altered circadian activity patterns
Frontiers in Behavioral Neuroscience 2014cited by 1position: middledoi
Abstract 2750: Conditional RNAi-mediated knockdown of TPX2 synergizes with vincristine and docetaxel cytotoxicity against HeLa cell sub-clones <i>in vitro</i> and <i>in vivo</i>
Cancer Research 2014cited by 0position: middledoi
A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats
Brain 2013cited by 169position: middledoi
Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function
Proceedings of the National Academy of Sciences 2013cited by 56position: middledoi
Transforming Growth Factor Beta Receptor 2 (TGFBR2) Changes Sialylation in the Microsatellite Unstable (MSI) Colorectal Cancer Cell Line HCT116
PLoS ONE 2013cited by 37position: middledoi
Nogo-A downregulation impairs place avoidance in the Carousel maze but not spatial memory in the Morris water maze
Neurobiology of Learning and Memory 2013cited by 26position: middledoi
N-Methyl-d-Aspartate Receptor – Nitric Oxide Synthase Pathway in the Cortex of Nogo-A-Deficient Rats in Relation to Brain Laterality and Schizophrenia
Frontiers in Behavioral Neuroscience 2013cited by 13position: middledoi
Conditional gene expression systems in the transgenic rat brain
BMC Biology 2012cited by 44position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Dušan Bartsch · University Hospital Heidelberg7 papers (2012–2014)Björn Tews · German Cancer Research Center6 papers (2013–2019)Stefan Berger · University Hospital Heidelberg5 papers (2013–2014)Martin E. Schwab · California Institute for Regenerative Medicine5 papers (2013–2019) · 3 papers (2013–2014) · 3 papers (2013–2014) · 2 papers (2013–2013)Franciscus van der Hoeven · German Cancer Research Center2 papers (2022–2022) · 2 papers (2013–2014)Thomas Enkel · University Hospital Heidelberg2 papers (2013–2014)Tillmann Weber · University Hospital Heidelberg1 papers (2012–2012)Dennis Strand · Johannes Gutenberg University Mainz1 papers (2017–2017)Jim Kent · University of California, Santa Cruz1 papers (2016–2016)Detlef Schuppan · Johannes Gutenberg University Mainz1 papers (2017–2017) · 1 papers (2013–2013)Anthony Adame · University of California, San Diego1 papers (2013–2013)Juergen Kopitz · Heidelberg University1 papers (2013–2013)Jean‐Stéphane Joly · Institut Pasteur1 papers (2016–2016) · 1 papers (2013–2013) · 1 papers (2016–2016)